Categories Consumer, U.S. Markets News

Tilray is on a consolidation spree

On the heels of a string of partnership deals, Tilray (TLRY) on Tuesday announced that it was acquiring Canada-based Natura Naturals Holdings Inc, a licensed cultivator of cannabis.

The deal gives Tilray Natura’s 662,000 square-foot greenhouse cultivation facility. Under the deal, Tilray would pay Natura CAD 15 million in cash and CAD 20 million in Tilray Class 2 common stock.

If Natura achieves certain milestones over the next year, the company would be entitled to up to another CAD 35 million of Tilray stock, lifting the total deal value to CAD 70 million.

tilray, canopy stocks
Photo by Sharon McCutcheon on Unsplash (Image for representation)

The transaction is expected to be completed in a month’s time. TLRY shares fell over 5% on Tuesday.

Tilray has been on a consolidation spree lately and the deal with Natura marks the fourth in less than 40 days. Last week, the company had inked a $100-million partnership with brand management company Authentic Brands Group.

Under the long-term revenue-sharing agreement, both the parties would together develop and distribute weed-based consumer products in regions where regulators have shown a green flag. The products are likely to hit Canada and the US by next year.

Budweiser-parent mulls pot-based drinks, inks JV with Tilray

This agreement comes barely a month after AB InBev (BUD), the maker of Budweiser beer, inked a $100-million deal with Tilray to study the production and distribution of non-alcoholic drinks infused with cannabis components. The joint venture, in its initial phase, is focused only in Canada.

A couple of days before the deal with AB InBev, Tilray sealed another agreement with German company Sandoz, a subsidiary of Novartis (NVS). Under this agreement, the two companies would collaborate to make new medical marijuana products and co-brand some non-combustible products.

 

Follow our Google News edition to get the latest stock market, earnings, and financial news at your fingertips 

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top